What is the price-to-earnings ratio of aTyr Pharma?
The price-earnings ratio of aTyr Pharma is currently -1.29.
aTyr Pharma P/E 2024
aTyr Pharma P/E
-1.29
aTyr Pharma Dividend yield
Ticker
LIFE
ISIN
US0021202025
WKN
A2PM86
As of Apr 27, 2024, aTyr Pharma's P/E ratio was -1.29, a -46.47% change from the -2.41 P/E ratio recorded in the previous year.
The aTyr Pharma P/E history
aTyr Pharma Aktienanalyse
What does aTyr Pharma do?
aTyr Pharma Inc is a biotechnology company based in San Diego, California. Founded in 2005, the company has gained a lot of attention in recent years for its focus on developing drugs based on proteomics, the analysis of proteins. The idea for aTyr came from the realization that there are a variety of proteins that can be used as a basis for developing new drugs. The company has developed a unique proteomics platform that allows for the identification and utilization of previously undiscovered proteins to understand biological processes and develop new drugs for diseases. aTyr specializes in the discovery and development of proteins associated with rare but difficult-to-treat diseases. This includes rare muscle diseases and lung diseases. The company collaborates closely with clinicians and scientists to advance its research and development. aTyr's business model is based on the development of new drugs based on proteomics, with a focus on rare diseases that are often neglected. The goal is to improve the quality of life for patients by developing new and innovative drugs. aTyr has various divisions, including therapeutic proteins and diagnostics. The company has a number of drugs in development targeting different diseases. This includes Resolaris, a protein focused on rare muscle diseases, and ATYR1923, developed for the treatment of lung diseases. Resolaris is a novel protein targeting rare muscle diseases such as FSHD and LGMD. It is currently being tested in clinical trials and has the potential to significantly improve the quality of life for patients with these severe conditions. The company is also developing ATYR1923, a protein for the treatment of lung diseases such as idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Overall, aTyr Pharma is an innovative company focused on the development of novel drugs based on proteomics. With its unique proteomics platform, the company has the potential to identify and utilize previously undiscovered proteins to understand biological processes and develop new drugs for diseases. With its various divisions, including therapeutic proteins and diagnostics, the company has the potential to improve the treatment of rare and difficult-to-treat diseases and enhance the lives of patients worldwide. aTyr Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering aTyr Pharma's P/E Ratio
The Price to Earnings (P/E) Ratio of aTyr Pharma is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing aTyr Pharma's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of aTyr Pharma is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in aTyr Pharma’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about aTyr Pharma Stock
How has the price-earnings ratio of aTyr Pharma changed compared to last year?
The price-to-earnings ratio of aTyr Pharma has increased by -46.47% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of aTyr Pharma high compared to other companies?
Yes, the price-to-earnings ratio of aTyr Pharma is high compared to other companies.
How does an increase in the price-earnings ratio of aTyr Pharma affect the company?
An increase in the price-earnings ratio of aTyr Pharma would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of aTyr Pharma affect the company?
A decrease in the price-earnings ratio of aTyr Pharma would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of aTyr Pharma?
Some factors that influence the price-earnings ratio of aTyr Pharma are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does aTyr Pharma pay?
Over the past 12 months, aTyr Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, aTyr Pharma is expected to pay a dividend of 0 USD.
What is the dividend yield of aTyr Pharma?
The current dividend yield of aTyr Pharma is .
When does aTyr Pharma pay dividends?
aTyr Pharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of aTyr Pharma?
aTyr Pharma paid dividends every year for the past 0 years.
What is the dividend of aTyr Pharma?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is aTyr Pharma located?
aTyr Pharma is assigned to the 'Health' sector.
Wann musste ich die Aktien von aTyr Pharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of aTyr Pharma from 4/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/27/2024.
When did aTyr Pharma pay the last dividend?
The last dividend was paid out on 4/27/2024.
What was the dividend of aTyr Pharma in the year 2023?
In the year 2023, aTyr Pharma distributed 0 USD as dividends.
In which currency does aTyr Pharma pay out the dividend?
The dividends of aTyr Pharma are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The aTyr Pharma stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von aTyr Pharma
Our stock analysis for aTyr Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of aTyr Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
